Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2021), 77, 4, (441-464), 10.1007/s00228-020-03014-8)

Anna Mueller-Schoell, Stefanie L. Groenland, Oliver Scherf-Clavel, Madelé van Dyk, Wilhelm Huisinga, Robin Michelet, Ulrich Jaehde, Neeltje Steeghs, Alwin D.R. Huitema, Charlotte Kloft

Research output: Contribution to journalComment/debate

Abstract

Due to an error during production, some in-text and most of the in-table citations were not correctly displayed in the original previous online version of the article and have now been corrected. The original article has been corrected.

Original languageEnglish
Pages (from-to)465
Number of pages1
JournalEuropean Journal of Clinical Pharmacology
Volume77
Issue number4
Early online date15 Dec 2020
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Targeted antineoplastic drugs
  • Tyrosine kinase inhibitors
  • Therapeutic drug monitoring
  • Oral anticancer drugs
  • Personalised medicine

Fingerprint

Dive into the research topics of 'Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2021), 77, 4, (441-464), 10.1007/s00228-020-03014-8)'. Together they form a unique fingerprint.

Cite this